Angiogenesis Inhibitors: all 4,430 studies that test it
Page 31 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab InjectionsTerminatedNCT02002377Phase 4
- Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠBStatus unknownNCT02001168Phase 3
- Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS TumorsCompletedNCT01999270Phase 1
- A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaCompletedNCT01998971Phase 1
- A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRCCompletedNCT01996306Phase 3
- A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerCompletedNCT01995188Phase 1
- AMG 386 Drug-Drug Interaction Study With PaclitaxelCompletedNCT01992341Phase 1
- A Phase 1 QT Study in Healthy Male SubjectsCompletedNCT01986894Phase 1
- Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer PatientsStatus unknownNCT01980472Phase 2
- Open Label Extension Study of HT-100 in Patients With DMDTerminatedNCT01978366Phase 2
- Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic RetinopathyCompletedNCT01976923Phase 3
- High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITPWithdrawnNCT01976195Phase 2
- Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.CompletedNCT01972763Phase 1/2
- Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited MetastasesCompletedNCT01972490Phase 4
- Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)CompletedNCT01971658Phase 3
- Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous ChorioretinopathyCompletedNCT01971190Phase 2
- Ranibizumab Treatment for Retinal Vein OcclusionStatus unknownNCT01968616Not applicable
- Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic MyopiaCompletedNCT01968486Phase 1
- Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCTCompletedNCT01968239Phase 2
- Salvage Chemotherapy for Poor Prognosis Germ Cell TumorsStatus unknownNCT01966913Phase 1/2
- A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple MyelomaCompletedNCT01965353Phase 1
- Intravitreal Aflibercept Injections In The Treatment Of Pattern DystrophyWithdrawnNCT01965041Not applicable
- Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver MetastasisStatus unknownNCT01962376Phase 4
- Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910Status unknownNCT01961414Phase 4
- Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System LymphomaCompletedNCT01956695Phase 2
- Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaActive, not recruitingNCT01955499Phase 1
- Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple MyelomaTerminatedNCT01954784Phase 1
- Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab FailureTerminatedNCT01954030Phase 1
- Pemetrexed/Platinum With or Without Bevacizumab in Brain Metastases From Patients With EGFR/ALK Negative Non-Squamous Non-small Cell Lung CancerCompletedNCT01951482Phase 3
- Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination ChemotherapyWithdrawnNCT01941173Not applicable
- A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular DegenerationCompletedNCT01941082Phase 1
- Pharmacokinetic Study of Thalidomide in Subjects With Multiple MyelomaCompletedNCT01937442Phase 1
- Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)CompletedNCT01936532Phase 2
- 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast CancerCompletedNCT01935492Phase 3
- An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerCompletedNCT01932125Phase 4
- Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT01924624Not applicable
- Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular GlaucomaCompletedNCT01922154Phase 4
- Avastin+ GemAOD As First-Line Treatment in NK/T Cell LymphomaStatus unknownNCT01921790Phase 2
- Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.Status unknownNCT01918878Phase 4
- A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.CompletedNCT01916447Phase 1
- Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01915134Phase 3
- A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast CancerStatus unknownNCT01907529Phase 2/3
- Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial CarcinomaWithdrawnNCT01907308Phase 2
- Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT01904643Phase 1
- Efficacy Study of Lucentis in the Treatment of RetinoblastomaStatus unknownNCT01899066Phase 2
- Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth FactorCompletedNCT01896284Phase 4
- A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade GliomaCompletedNCT01891747Phase 1
- Thalidomide in the Treatment of Chronic Plaque Psoriasis.CompletedNCT01891019Phase 2
- Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal CancerWithdrawnNCT01889680Phase 2
- Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01886859Phase 1
- Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast CancerStatus unknownNCT01880385Phase 1
- Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapyActive, not recruitingNCT01871766Phase 2
- Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or ExudationCompletedNCT01871376Phase 4
- NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein OcclusionsCompletedNCT01870427Phase 4
- Using Aflibercept Injection to Treat Blood Vessel Growth Over the CorneaTerminatedNCT01868360Phase 1
- R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCLCompletedNCT01865110Phase 3
- Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)CompletedNCT01863199Phase 4
- A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With GlioblastomaCompletedNCT01860638Phase 2
- Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF TherapyStatus unknownNCT01857544Phase 4
- First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal CancerCompletedNCT01853813Phase 2
- Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant AscitesStatus unknownNCT01852409Phase 1
- Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional RegimenStatus unknownNCT01850147Phase 2
- Neoadjuvant Therapy in Advanced Ovarian Cancer With AvastinTerminatedNCT01847677Phase 2
- Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular DystrophyTerminatedNCT01847573Phase 1/2
- Ranibizumab For Persistent Diabetic Macular Edema After BevacizumabStatus unknownNCT01845844Phase 1/2
- Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion ChemotherapyStatus unknownNCT01838538Phase 2
- Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung CancerCompletedNCT01837329Phase 1
- Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian CancerCompletedNCT01837251Phase 3
- Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesCompletedNCT01836653Phase 2
- Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired MalesCompletedNCT01835561Phase 1
- Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver MetastasesCompletedNCT01834014Not applicable
- Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal CancerStatus unknownNCT01832948Phase 2
- Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.CompletedNCT01831947Phase 4
- Lenalidomide Plus Rituximab (R) in Non Follicular NHLStatus unknownNCT01830478Phase 2
- Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular LymphomaActive, not recruitingNCT01829568Phase 1
- Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein OcclusionStatus unknownNCT01827722Phase 4
- Sunitinib® in Patients With Recurrent Ovarian Clear Cell CarcinomaCompletedNCT01824615Phase 2
- Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular DegenerationCompletedNCT01824225Phase 4
- Use of Intravitreal Ranibizumab in the Treatment of Vitreous HemorrhageStatus unknownNCT01824043Phase 4
- Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual ImpairmentCompletedNCT01823965Phase 2
- Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular EdemaCompletedNCT01823081Phase 3
- Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal CancerStatus unknownNCT01818973Phase 2
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi SyndromeCompletedNCT01818921Phase 2
- Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS SyndromeCompletedNCT01816620Phase 2
- Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T StudyCompletedNCT01813773Phase 2/3
- Endostar + GT in Pulmonary Metastases of Soft Tissue SarcomaStatus unknownNCT01812018Phase 2
- Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL AmyloidosisTerminatedNCT01807286Phase 1
- Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid TumorsStatus unknownNCT01803503Phase 2
- Bevacizumab Beyond Progression in Platinum Sensitive Ovarian CancerStatus unknownNCT01802749Phase 3
- OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal CancerCompletedNCT01802684Phase 2
- Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver MetastasesStatus unknownNCT01802645Phase 2
- Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair VisionTerminatedNCT01795209Phase 4
- Treatment for Presumed Ocular HistoplasmosisStatus unknownNCT01790893Phase 1/2
- Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell LymphomasCompletedNCT01788189Phase 1/2
- Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01787669Phase 2
- Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal CancerTerminatedNCT01784978Phase 2
- Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)WithdrawnNCT01782976Phase 2
- PRevention of Macular EDema After Cataract SurgeryCompletedNCT01774474Phase 3
- Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)CompletedNCT01770301Phase 2
- Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial CancerStatus unknownNCT01770171Phase 2